This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignees: Destiny Pharma Limited, Solvias Ag. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2007
Title: Xiang Dong Feng: Innovator in Photodynamic Therapy
Introduction
Xiang Dong Feng is a notable inventor based in Basel, Switzerland. She has made significant contributions to the field of photodynamic therapy through her innovative research and development of porphyrin derivatives. Her work focuses on compounds that have the potential to treat various medical conditions effectively.
Latest Patents
Xiang Dong Feng holds a patent for "Porphyrin derivatives and their use in photodynamic therapy." This patent describes a compound of formula I, wherein specific elements have meanings provided in the description. The metallated forms of these compounds are particularly useful in treating medical conditions where a photodynamic compound is indicated. Additionally, the patent discloses pharmaceutical formulations and methods of treatment involving these photodynamic agents. It also includes sterilizing solutions comprising a compound of the invention and their applications.
Career Highlights
Throughout her career, Xiang Dong Feng has worked with prominent companies such as Destiny Pharma Limited and Solvias AG. Her experience in these organizations has allowed her to advance her research and contribute to the development of innovative medical solutions.
Collaborations
Xiang has collaborated with notable individuals in her field, including William Guy Love and Derek Brundish. These partnerships have further enhanced her research and the impact of her inventions.
Conclusion
Xiang Dong Feng is a pioneering inventor whose work in photodynamic therapy has the potential to revolutionize treatment options for various medical conditions. Her contributions to the field are significant and continue to inspire future innovations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile